Why should the primary container system be considered an excipient? Register for West’s webinar on December 5, to gain insight on considerations that should be made to mitigate packaging risks early in the drug development process!
The number of pediatric drug approvals has increased 5 fold over the last 20 years, rising from 10-20 approvals per year to 50-60 annually today. Increased awareness around pediatric medicine and FDA support for pediatric clinical research are just some of the factors contributing to this growing market.
Cornell Professor Ulrich Wiesner’s C-dots are showing more and more that they could be the next big step in nanotech drug delivery. In their latest incarnation, the diagnostic and delivery combination particles have shown that they can alone deprive cancer cells of nutrients, resulting in their death.